Gefitinib-Induced Interstitial Lung Disease in Korean Lung Cancer Patients

PURPOSE: Interstitial lung disease (ILD) is a serious adverse effect of gefitinib. We examined the incidence and clinical characteristics of drug-induced ILD in Korean non-small cell lung carcinoma patients treated with gefitinib. MATERIALS AND METHODS: A retrospective cohort study was performed in...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Res Treat
Main Authors: Beom, Seung-Hoon, Kim, Dong-Wan, Sim, Sung Hoon, Keam, Bhumsuk, Park, Jin Hyun, Lee, Jeong-Ok, Kim, Tae Min, Lee, Se-Hoon, Heo, Dae Seog
Formato: Artigo
Idioma:Inglês
Publicado: Korean Cancer Association 2016
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4720097/
https://ncbi.nlm.nih.gov/pubmed/25761482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2014.201
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares